293.85
0.64%
-1.88
Bio-Rad Laboratories Inc. 주식(BIO)의 최신 뉴스
BNP Paribas Financial Markets Buys 12,662 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments - Yahoo Movies UK
Yahoo Movies UK
Chromatography Resins Market 2024 Size, Global Report till 2031 | Bio-Rad Laboratories Inc, GE Healthcare Life ... - openPR
openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Victory Capital Management Inc. - Defense World
Defense World
5,163 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Jump Financial LLC - MarketBeat
MarketBeat
Genomics Market Detailed In New Research Report 2024 | Bio-Rad Laboratories, Inc., Illumina, Inc., Pacific ... - openPR
openPR
Oncology Liquid Biopsy (LBx) Market Analysis, Research Study With Bio-Rad Laboratories, Biocept Inc., Guardant Health - openPR
openPR
Here's Why You Should Retain Bio-Rad (BIO) Stock for Now - Yahoo Singapore News
Yahoo Singapore News
Point-of-Care Diagnostics Global Report 2024-2030 Featuring Sysmex, Abbott Laboratories, BD and Co, Danaher ... - Manchestertimes
Manchestertimes
Macrophage Marker Market to See Booming Growth 2024-2031 | Abcam plc, Bio-Rad Laboratories, GeneTex, Inc, - EIN News
EIN News
Bio-Rad Laboratories (NYSE:BIO.B) Shares Down 17.3% - MarketBeat
MarketBeat
M&T Bank Corp Reduces Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Defense World
Roubaix Capital LLC Makes New $4.05 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
Here's Why You Should Invest in Bio-Rad (BIO) Stock Now - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
Here's Why You Should Retain Bio-Rad (BIO) Stock for Now - Yahoo New Zealand News
Yahoo New Zealand News
Electrophoresis Reagents Market Size 2024-2031: Industrial Overv - SOUTHEAST - News Channel Nebraska
News Channel Nebraska
Bio-Rad Laboratories, Inc. (NYSE:BIO) Holdings Lowered by Metis Global Partners LLC - Defense World
Defense World
Mawer Investment Management Ltd. Sells 38,954 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
Russell Investments Group Ltd. Has $4.91 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Defense World
Bio-Rad Laboratories (NYSE:BIO) PT Lowered to $385.00 at UBS Group - Defense World
Defense World
Natixis Advisors L.P. Increases Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
Wall Street Analysts Predict a 28.56% Upside in Bio-Rad (BIO): Here's What You Should Know - Yahoo Movies UK
Yahoo Movies UK
Natixis Advisors L.P. Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Defense World
Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results - Yahoo Finance
Yahoo Finance
Blood Group Typing Technology Market 2023-2030 Insight View with Size and Growth Analysis | Research Report by ... - News Channel Nebraska
News Channel Nebraska
Genomics Market Size and Share 2023-2030 Detailed Analysis by Regions, Countries, Types, Applications and ... - News Channel Nebraska
News Channel Nebraska
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Swiss National Bank - Defense World
Defense World
Swiss National Bank Decreases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
Retirement Systems of Alabama Has $1.49 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Defense World
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip - Yahoo News Canada
Yahoo News Canada
Here's Why You Should Invest in Bio-Rad (BIO) Stock Now - Yahoo News Australia
Yahoo News Australia
Bio-Rad Laboratories Up 7% After Investor Day - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Expectations By $0.25 EPS - MarketBeat
MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55 - MarketBeat
MarketBeat
UBS Group Trims Bio-Rad Laboratories (NYSE:BIO) Target Price to $385.00 - MarketBeat
MarketBeat
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Zacks Investment Research
Zacks Investment Research
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Yahoo Finance UK
Yahoo Finance UK
Bio-Rad Laboratories is Now Oversold (BIO) - Nasdaq
Nasdaq
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories - Bio-Rad Laboratories (NYSE:BIO) - Benzinga
Benzinga
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - MSN
MSN
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript - Yahoo Finance Australia
Yahoo Finance Australia
Bio-Rad Expands Range of Antibody Markers - Lab Manager Magazine
Lab Manager Magazine
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook - Investing.com
Investing.com
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Zacks Investment Research
Zacks Investment Research
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - InvestorPlace
InvestorPlace
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - TradingView
TradingView
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates - Zacks Investment Research
Zacks Investment Research
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates - Yahoo Finance UK
Yahoo Finance UK
Truist Financial Corp Cuts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
MarketBeat
자본화:
|
볼륨(24시간):